BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 13, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Umbilical cord mesenchymal stem cells: Phase I data

In a Phase I trial in 114 patients with non-hematopoietic degenerative conditions, stem cell transplantation with UC-MSCs was well tolerated with no serious adverse effects reported at up to 4...

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >